ulcerative colitiis

Galapagos’ Jyseleca gets UK marketing authorization for ulcerative colitis
Pharmaceutical Business Review
Wed, 01/19/22 - 10:57 am
Galapagos
UK
ulcerative colitiis
Jyseleca
filgotinib